Objective To summarize the clinical effects and nursing methods of TR-350 immunoadsorption in treatment of the national rare disease, the neuromyelitis optica spectrum disorders. Methods General
situation of the patients, abnormal reactions during treatment, equipment alarm, management and clinical results were collected. Results Visual acuity and nerve function improved significantly after the immunoadsorption treatment. The extended disability status scale (EDSS) reduced from (5.84 ± 2.16) to (4.46 ± 2.13)
(t=5.404, P=0.005). The concentration of anti- aquaporin- 4 autoantibody also decreased significantly from
(72.14±24.21)μ/ml to (16.72±6.63)μ/ml (t =10.793, P＜0.001). In the 68 cases during treatment, hypotension
occurred in one case, catarrh symptoms in 5 cases, equipment alarm in 14 cases, and unplanned termination of
the treatment in one case. Conclusions The immunoadsorption effect is obvious but the operation is complicated. Therefore, the operation nurses are required to strictly follow the operation processes, and have the abilities to analyze the cause of equipment alarm and to manage the emergencies to ensure success of the treatment.
XIONG Yun-Jin
,
GU Jing
,
GONG Yong
,
ZHANG Yin
,
ZHOU Yi-Lun
. TR-350 immunoadsorption used in the neuromyelitis optica spectrum disorders: its clinical effects and#br#
nursing methods[J]. Chinese Journal of Blood Purification, 2022
, 21(07)
: 541
-544
.
DOI: 10.3969/j.issn.1671-4091.2022.07.017
[1]Hardy T A, Reddel S W, Barnett M H, et al.Atypical inflammatory demyelinating syndromes of the CNS[J].Lancet Neurol, 2016, 15(9):967-981
[2] 中国视神经脊髓炎谱系疾病诊断与治疗指南[J].中国神经免疫学和神经病学杂志, 2016, 23(03):155-166.[J].中国神经免疫学和神经病学杂志, 2016, 23(03):155-166
[3]Sellner J, Boggild M, Clanet M, et al.EFNS guidelines on diagnosis and management of neuromyelitis optica[J].Eur J Neurol, 2010, 17(8):1019-1032
[4]Oji S, Nomura K.Immunoadsorption in neurological disorders[J].Transfus Apher Sci, 2017, 56(5):671-676
[5]Heigl F, Hettich R, Arendt R, et al.Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients[J].Atheroscler Suppl, 2013, 14(1):167-173
[6]K?hler W, Bucka C, Klingel R.A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis[J].Journal of Clinical Apheresis, 2011, 26(6):347-355
[7]Michael J Koziolek, Desiree Tampe, Matthias B?hr2, Hassan Dihazi, Klaus Jung, Dirk Fitzner, Reinhard Klingel, Gerhard A Müller and Bernd Kitze: Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.Journal of Neuroinflammation 2012, 9:80[J].Journal of Neuroinflammation , 2012, 9(9):80-80
[8]Padmanabhan A, Connelly-Smith L, Aqui N, et al.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue[J].J Clin Apher, 2019, 34(3):171-354
[9]Cinar B P, Yorgun Y G.What We Learned from The History of Multiple Sclerosis Measurement: Expanded Disability Status Scale[J].Noro Psikiyatr Ars, 2018, 55(Suppl 1):S69-S75
